NYSE:ACAArcosa Stock Price, Forecast & News

Arcosa's stock was trading at $37.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACA shares have increased by 23.8% and is now trading at $45.87.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Arcosa.

Arcosa is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Arcosa.

Arcosa Inc (NYSE:ACA) announced its quarterly earnings data on Thursday, July, 30th. The company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.60 by $0.13. The firm had revenue of $498.50 million for the quarter, compared to analysts' expectations of $498.30 million. Arcosa had a net margin of 6.32% and a return on equity of 6.86%.
View Arcosa's earnings history.

Arcosa declared a quarterly dividend on Tuesday, May 5th. Stockholders of record on Wednesday, July 15th will be paid a dividend of $0.05 per share on Friday, July 31st. This represents a $0.20 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend is Tuesday, July 14th.
View Arcosa's dividend history.

4 brokerages have issued 1 year target prices for Arcosa's shares. Their forecasts range from $48.00 to $61.00. On average, they expect Arcosa's share price to reach $53.00 in the next year. This suggests a possible upside of 15.5% from the stock's current price.
View analysts' price targets for Arcosa.

Media coverage about ACA stock has trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Arcosa earned a media sentiment score of -1.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about Arcosa.

Arcosa saw a drop in short interest in January. As of January 15th, there was short interest totaling 770,600 shares, a drop of 39.3% from the December 31st total of 1,270,000 shares. Based on an average daily trading volume, of 335,400 shares, the short-interest ratio is presently 2.3 days. Currently, 1.6% of the shares of the stock are short sold.
View Arcosa's Short Interest.

Some companies that are related to Arcosa include Proto Labs (PRLB), Valmont Industries (VMI), HC2 (HCHC), Gulf Island Fabrication (GIFI) and TechPrecision (TPCS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include AbbVie (ABBV), Walt Disney (DIS), DexCom (DXCM), AT&T (T), Xilinx (XLNX), Advanced Micro Devices (AMD), NVIDIA (NVDA), Pfizer (PFE), Splunk (SPLK) and Axon Enterprise (AAXN).

Arcosa trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACA."

Arcosa's stock is owned by many different institutional and retail investors. Top institutional investors include Copper Rock Capital Partners LLC (37.27%), Bank of New York Mellon Corp (1.29%), Yacktman Asset Management LP (0.85%), Russell Investments Group Ltd. (0.79%), Principal Financial Group Inc. (0.77%) and Thompson Siegel & Walmsley LLC (0.68%). Company insiders that own Arcosa stock include Antonio Carrillo, Kerry S Cole, Ronald J Gafford and Valueact Capital Master Fund,.
View institutional ownership trends for Arcosa.

ACA stock was sold by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, WINTON GROUP Ltd, Goldman Sachs Group Inc., Russell Investments Group Ltd., UBS Group AG, Bessemer Group Inc., First Trust Advisors LP, and Yacktman Asset Management LP. Company insiders that have sold Arcosa company stock in the last year include Kerry S Cole, and Ronald J Gafford.
View insider buying and selling activity for Arcosa.

ACA stock was bought by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Dalton Greiner Hartman Maher & Co., Mutual of America Capital Management LLC, Great Lakes Advisors LLC, Swiss National Bank, Emerald Mutual Fund Advisers Trust, Aptus Capital Advisors LLC, and SG Americas Securities LLC.
View insider buying and selling activity for Arcosa.

Shares of ACA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACA stock can currently be purchased for approximately $45.87.

Arcosa has a market capitalization of $2.22 billion and generates $1.74 billion in revenue each year. The company earns $113.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Arcosa employs 6,275 workers across the globe.

The official website for Arcosa is www.arcosa.com.

Arcosa's mailing address is 500 N. Akard Street Suite 400, DALLAS TX, 75201. The company can be reached via phone at 972-942-6500 or via email at [email protected]